GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

NCT07314684 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: semaglutide
DRUG: Standard Treatment (Guideline-Based)

Sponsor

Federico II University